Characteristics Associated with Functional Changes During Systemic Cancer Treatments: A Systematic Review Focused on Older Adults
Previous
Previous
Phase I/II Trial of Palbociclib, Pembrolizumab, and Letrozole in Patients with Hormone Receptor-Positive Metastatic Breast Cancer
Next
Next